Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Cell Reports. Medicine
|
June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cells
Alexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Cancer Research
|
November 21, 2025
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer
Rajendra Kumar, Sheila Jonnatan, David E Sanin, et al.
European Urology Oncology
|
July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer
Sandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer
A Mandl, S Jasmine, Teg Krueger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Proceedings. Biological Sciences
|
March 12, 2024
Academic publishing requires linguistically inclusive policies
Henry Arenas-Castro, Violeta Berdejo-Espinola, Shawan Chowdhury, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Cell Reports. Medicine
|
June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cells
Alexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Cancer Research
|
November 21, 2025
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer
Rajendra Kumar, Sheila Jonnatan, David E Sanin, et al.
European Urology Oncology
|
July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer
Sandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer
A Mandl, S Jasmine, Teg Krueger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Proceedings. Biological Sciences
|
March 12, 2024
Academic publishing requires linguistically inclusive policies
Henry Arenas-Castro, Violeta Berdejo-Espinola, Shawan Chowdhury, et al.
Page
of 9